S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
AMEX
Lorus Therapeutics, (New) (LRP)
Lorus Therapeutics, (New) (LRP) News

LRP

Lorus Therapeutics (LRP)

Lorus Therapeutics, (New)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:LRP

1 2 3 4 5 6 7 Next >>

Date	Time	Source	Headline	Symbol	Company
10/21/2014	7:00AM	PR Newswire (US)	Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO	AMEX:LRP	Lorus Therapeutics, (New)
10/21/2014	7:00AM	PR Newswire (Canada)	Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO	AMEX:LRP	Lorus Therapeutics, (New)
10/03/2014	6:00AM	PR Newswire (US)	Aptose Biosciences to Present at the 2014 BIO Investor Forum	AMEX:LRP	Lorus Therapeutics, (New)
10/03/2014	6:00AM	PR Newswire (Canada)	Aptose Biosciences to Present at the 2014 BIO Investor Forum	AMEX:LRP	Lorus Therapeutics, (New)
10/01/2014	4:16PM	PR Newswire (Canada)	Aptose Biosciences Announces Reverse Stock Split	AMEX:LRP	Lorus Therapeutics, (New)
10/01/2014	4:16PM	PR Newswire (US)	Aptose Biosciences Announces Reverse Stock Split	AMEX:LRP	Lorus Therapeutics, (New)
09/29/2014	7:30AM	PR Newswire (US)	Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S...	AMEX:LRP	Lorus Therapeutics, (New)
09/29/2014	7:30AM	PR Newswire (Canada)	Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S...	AMEX:LRP	Lorus Therapeutics, (New)
09/25/2014	8:48AM	PR Newswire (US)	Aptose Biosciences to Present at Upcoming Investor Conferences	AMEX:LRP	Lorus Therapeutics, (New)
09/25/2014	8:48AM	PR Newswire (Canada)	Aptose Biosciences to Present at Upcoming Investor Conferences	AMEX:LRP	Lorus Therapeutics, (New)
09/08/2014	6:00AM	PR Newswire (US)	Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer	AMEX:LRP	Lorus Therapeutics, (New)
09/08/2014	6:00AM	PR Newswire (Canada)	Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer	AMEX:LRP	Lorus Therapeutics, (New)
09/02/2014	6:00AM	PR Newswire (US)	Lorus Therapeutics Implements Name Change to Aptose Biosciences	AMEX:LRP	Lorus Therapeutics, (New)
09/02/2014	6:00AM	PR Newswire (Canada)	Lorus Therapeutics Implements Name Change to Aptose Biosciences	AMEX:LRP	Lorus Therapeutics, (New)
08/19/2014	3:00PM	PR Newswire (US)	Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders	AMEX:LRP	Lorus Therapeutics, (New)
08/19/2014	3:00PM	PR Newswire (Canada)	Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders	AMEX:LRP	Lorus Therapeutics, (New)
08/07/2014	6:00AM	PR Newswire (US)	Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth Conference	AMEX:LRP	Lorus Therapeutics, (New)
08/07/2014	6:00AM	PR Newswire (Canada)	Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth Conference	AMEX:LRP	Lorus Therapeutics, (New)
07/28/2014	6:00AM	PR Newswire (US)	Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo...	AMEX:LRP	Lorus Therapeutics, (New)
07/28/2014	6:00AM	PR Newswire (Canada)	Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo...	AMEX:LRP	Lorus Therapeutics, (New)
07/15/2014	3:46PM	PR Newswire (US)	Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014	AMEX:LRP	Lorus Therapeutics, (New)
07/15/2014	3:46PM	PR Newswire (Canada)	Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014	AMEX:LRP	Lorus Therapeutics, (New)
07/15/2014	3:28PM	PR Newswire (US)	Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing	AMEX:LRP	Lorus Therapeutics, (New)
07/15/2014	3:28PM	PR Newswire (Canada)	Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing	AMEX:LRP	Lorus Therapeutics, (New)
07/10/2014	6:00AM	PR Newswire (US)	Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast	AMEX:LRP	Lorus Therapeutics, (New)
07/10/2014	6:00AM	PR Newswire (Canada)	Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast	AMEX:LRP	Lorus Therapeutics, (New)
06/19/2014	6:00AM	PR Newswire (US)	Lorus Therapeutics to Present at the 9th JMP Securities Healthcare Conference	AMEX:LRP	Lorus Therapeutics, (New)
06/19/2014	6:00AM	PR Newswire (Canada)	Lorus Therapeutics to Present at the 9th JMP Securities Healthcare Conference	AMEX:LRP	Lorus Therapeutics, (New)
06/16/2014	6:00AM	PR Newswire (Canada)	Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference	AMEX:LRP	Lorus Therapeutics, (New)
06/16/2014	6:00AM	PR Newswire (US)	Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference	AMEX:LRP	Lorus Therapeutics, (New)

Showing the most relevant articles for your search:AMEX:LRP

1 2 3 4 5 6 7 Next >>

MicroCloud Hologram

Cann American (CE)

Ubiquitech Software (PK)

NaturalShrimp (QB)

Brookmount Explorations (PK)

Bioelectronics (PK)

Atlantic Energy Solutions (PK)

TransCode Therapeutics

TideRock Companies (PK)

Clean Vision (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions